Oncostatin M in Combination with Tumour Necrosis Factor {alpha} Induces a Chondrocyte Membrane Associated Aggrecanase That is Distinct from ADAMTS Aggrecanase-1 or -2

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2005 May 11

PMID 15883123

Citations 13

Authors

W Hui

H E Barksby

D A Young

T E Cawston

N McKie

A D Rowan

Affiliations

Soon will be listed here.

Abstract

Objective: To determine whether oncostatin M (OSM) + tumour necrosis factor alpha (TNFalpha) induces aggrecanase activity in chondrocyte membranes, to determine the effects of transforming growth factor beta1 (TGFbeta1), interleukin 4 (IL4), and tissue inhibitor of metalloproteinases (TIMPs) on this activity, and to determine whether this activity is due to a known ADAMTS aggrecanase.

Methods: Aggrecanase activity and ability of agents to prevent membrane associated aggrecanase activity were assessed by Western blotting. Expression of known aggrecanases was measured by real time polymerase chain reaction in bovine nasal and human articular chondrocytes.

Results: Chondrocyte membrane associated aggrecanase activity and increased mRNA expression of ADAMTS-1, -4, -5, and -9, but not ADAMTS-4 or -15, were enhanced after stimulation by OSM+TNFalpha in bovine chondrocytes. This activity was inhibited by TIMP-3. In human chondrocytes, OSM+TNFalpha also enhanced ADAMTS-1 and -4 expression, but not that of other ADAMTSs. TNFalpha alone induced ADAMTS-9 expression, whereas OSM addition caused suppression. Both TGFbeta1 and IL4 blocked membrane associated aggrecanase activity and decreased OSM+TNFalpha-induced expression of ADAMTS-9 in bovine and human chondrocytes. IL4 down regulated ADAMTS-4 mRNA, whereas TGFbeta1 increased this expression in both bovine and human chondrocytes.

Conclusions: OSM+TNFalpha up regulates membrane associated aggrecanase activity and several ADAMTS aggrecanase mRNAs in chondrocytes. The chondroprotective effects of IL4 and TIMP-3 suggest that they may have therapeutic benefit for aggrecanolysis, whereas the differential inhibitory effects of TGFbeta1 may limit its therapeutic potential. Induced membrane associated aggrecanase activity is distinct from known soluble ADAMTS aggrecanases and merits further investigation.

Citing Articles

The Effect of Mesenchymal Stem Cell Wharton's Jelly on Matrix Metalloproteinase-1 and Interleukin-4 Levels in Osteoarthritis Rat Model.

Endrinaldi E, Darwin E, Zubir N, Revilla G Open Access Maced J Med Sci. 2019; 7(4):529-535.

PMID: 30894907 PMC: 6420948. DOI: 10.3889/oamjms.2019.152.

The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover.

Wilkinson D, Desilets A, Lin H, Charlton S, Arques M, Falconer A Sci Rep. 2017; 7(1):16693.

PMID: 29196708 PMC: 5711915. DOI: 10.1038/s41598-017-17028-3.

Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms.

Wilkinson D, Wang H, Habgood A, Lamb H, Thompson P, Hawkins A Arthritis Rheumatol. 2017; 69(8):1601-1611.

PMID: 28464560 PMC: 5599990. DOI: 10.1002/art.40133.

Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M.

Khansai M, Boonmaleerat K, Pothacharoen P, Phitak T, Kongtawelert P BMC Complement Altern Med. 2016; 16:205.

PMID: 27400672 PMC: 4940911. DOI: 10.1186/s12906-016-1183-0.

Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis.

Gao S, Zeng C, Song Y, Tian J, Cheng C, Yang T Exp Ther Med. 2015; 9(5):1979-1983.

PMID: 26136925 PMC: 4471803. DOI: 10.3892/etm.2015.2310.

References

Koshy P, Lundy C, Rowan A, Porter S, Edwards D, Hogan A . The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum. 2002; 46(4):961-7. DOI: 10.1002/art.10212. View

Gao G, Westling J, Thompson V, Howell T, Gottschall P, Sandy J . Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J Biol Chem. 2002; 277(13):11034-41. DOI: 10.1074/jbc.M107443200. View

Rodriguez-Manzaneque J, Westling J, Thai S, Luque A, Knauper V, Murphy G . ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem Biophys Res Commun. 2002; 293(1):501-8. DOI: 10.1016/S0006-291X(02)00254-1. View

Malfait A, Liu R, Ijiri K, Komiya S, Tortorella M . Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem. 2002; 277(25):22201-8. DOI: 10.1074/jbc.M200431200. View

Koshy P, Henderson N, Logan C, Life P, Cawston T, Rowan A . Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis. 2002; 61(8):704-13. PMC: 1754191. DOI: 10.1136/ard.61.8.704. View

Bau B, Gebhard P, Haag J, Knorr T, Bartnik E, Aigner T . Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum. 2002; 46(10):2648-57. DOI: 10.1002/art.10531. View

Grimaud E, Heymann D, Redini F . Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev. 2002; 13(3):241-57. DOI: 10.1016/s1359-6101(02)00004-7. View

Hui W, Cawston T, Rowan A . Transforming growth factor beta 1 and insulin-like growth factor 1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor alpha from bovine cartilage. Ann Rheum Dis. 2003; 62(2):172-4. PMC: 1754447. DOI: 10.1136/ard.62.2.172. View

Pratta M, Scherle P, Yang G, Liu R, Newton R . Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. Arthritis Rheum. 2003; 48(1):119-33. DOI: 10.1002/art.10726. View

10.

Somerville R, Longpre J, Jungers K, Engle J, Ross M, Evanko S . Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem. 2003; 278(11):9503-13. DOI: 10.1074/jbc.M211009200. View

11.

Milner J, Rowan A, Elliott S, Cawston T . Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation. Arthritis Rheum. 2003; 48(4):1057-66. DOI: 10.1002/art.10873. View

12.

Nagase H, Kashiwagi M . Aggrecanases and cartilage matrix degradation. Arthritis Res Ther. 2003; 5(2):94-103. PMC: 165039. DOI: 10.1186/ar630. View

13.

Rowan A, Hui W, Cawston T, Richards C . Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model. Am J Pathol. 2003; 162(6):1975-84. PMC: 1868119. DOI: 10.1016/S0002-9440(10)64330-1. View

14.

Arris C, Bevitt D, Mohamed J, Li Z, Langton K, Barker M . Expression of mutant and wild-type TIMP3 in primary gingival fibroblasts from Sorsby's fundus dystrophy patients. Biochim Biophys Acta. 2003; 1638(1):20-8. DOI: 10.1016/s0925-4439(03)00036-x. View

15.

Robin Poole A, Nelson F, Dahlberg L, Tchetina E, Kobayashi M, Yasuda T . Proteolysis of the collagen fibril in osteoarthritis. Biochem Soc Symp. 2003; (70):115-23. DOI: 10.1042/bss0700115. View

16.

Hui W, Rowan A, Richards C, Cawston T . Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum. 2003; 48(12):3404-18. DOI: 10.1002/art.11333. View

17.

Gendron C, Kashiwagi M, Hughes C, Caterson B, Nagase H . TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors. FEBS Lett. 2003; 555(3):431-6. DOI: 10.1016/s0014-5793(03)01295-x. View

18.

Kevorkian L, Young D, Darrah C, Donell S, Shepstone L, Porter S . Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 2004; 50(1):131-41. DOI: 10.1002/art.11433. View

19.

Gao G, Plaas A, Thompson V, Jin S, Zuo F, Sandy J . ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate.... J Biol Chem. 2004; 279(11):10042-51. DOI: 10.1074/jbc.M312100200. View

20.

Moulharat N, Lesur C, Thomas M, Rolland-Valognes G, Pastoureau P, Anract P . Effects of transforming growth factor-beta on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro. Osteoarthritis Cartilage. 2004; 12(4):296-305. DOI: 10.1016/j.joca.2003.11.009. View